DLCI-1
DLCI-1 is a potent, selective, and orally bioavailable CYP2A6 inhibitor. It effectively decreases nicotine self-administration in murine models, supporting its utility for researching nicotine metabolism and addiction in both in vivo behavioral studies and in vitro enzymatic assays.
Product Specifications
CAS Number
2244569-14-8
Field of Research
Metabolism Research
Smiles
N=1C=CC (=C (C1) C=2SC (=CC2) CN) CC
Molecular Formula
C12H14N2S
Molecular Weight
218.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
